Ziyang Qiang
No. 29 Tongren Road
Xining, 810000, China
Xining, 810000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
ALKBH2 promotes the Warburg effect and bladder cancer progression under hypoxic conditions via the PI3K/AKT pathway.
Journal: Clinical and experimental medicine
Published: March 25, 2026
Nanomedicine-based sensitization and resistance reversal in immunotherapy of clear cell renal cell carcinoma: from tumor microenvironment to precision delivery.
Journal: Medical oncology (Northwood, London, England)
Published: March 24, 2026
Mechanisms and therapeutic implications of metabolic heterogeneity and histone lactylation in clear cell renal cell carcinoma.
Journal: Discover oncology
Published: February 07, 2026
A new target: AlkBH2 promotes bladder cancer by upregulation of inflammation.
Journal: PloS one
Published: November 27, 2025
Baicalin inhibits bladder cancer progression by suppressing PD-L1-mediated M2 macrophage polarization via ALDH2.
Journal: Biochemical and biophysical research communications
Published: September 03, 2025
Global research trends of robotic-assisted surgery in Urogynecology and Reconstructive Pelvic Surgery: a bibliometric and visualization analysis based on web of science.
Journal: Journal of robotic surgery
Published: August 30, 2025
Dysbiotic Gut Microbiota Correlates with Altered Serum and Urinary Biomarkers in Recurrent Calcium Oxalate Stone Patients.
Journal: International journal of general medicine
Published: June 26, 2025
Synchronous angiomyolipoma with epithelial cysts and clear cell renal cell carcinoma: a case report.
Synchronous angiomyolipoma with epithelial cysts and clear cell renal cell carcinoma: a case report.
Journal: Frontiers in oncology
Published: April 25, 2025
Risk Factor Analysis and Prediction Model Establishment for Urinary Incontinence after Laparoscopic Radical Prostatectomy.
Journal: Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
Published: April 22, 2025
Real-world effectiveness of rezvilutamide plus androgen deprivation therapy in patients with low-volume, metastatic hormone-sensitive prostate cancer: a retrospective multicenter study.
Journal: Translational andrology and urology
Published: March 28, 2025
Last Updated: 09/26/2026